Neoantigen load as a prognostic and predictive marker for stage II/III non‐small cell lung cancer in Chinese patients

BACKGROUND: The prognosis for patients with stage II/III non–small cell lung cancer (NSCLC) is unsatisfactory, even after complete tumor resection and adjuvant chemotherapy. Here, we assessed the prognostic and predictive value of immunogenomic signatures for stage II/III NSCLC in Chinese patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Lei, He, Ronghui, Xu, Yanjun, Luo, Taobo, Jin, Kaixiu, Yuan, Wuzhou, Zheng, Zengguang, Liu, Lanxuan, Liang, Zebin, Li, Ao, Zheng, Zhiguo, Li, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327700/
https://www.ncbi.nlm.nih.gov/pubmed/34128337
http://dx.doi.org/10.1111/1759-7714.14046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327700/
https://www.ncbi.nlm.nih.gov/pubmed/34128337
http://dx.doi.org/10.1111/1759-7714.14046

Ejemplares similares